24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet — RxCUI 861132
RxNorm drug concept · Semantic clinical drug
RxCUI 861132
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
49 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI861132
Official name24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asalfuzosin HCl 10 MG 24HR Extended Release Oral Tablet
FDA products mapped16
Package NDCs mapped49
Reported Medicaid activity (SDUD)80,100 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Alfuzosin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's designed to relax the muscles around your prostate and the outlet of your bladder. When those muscles loosen up, urine can flow more easily. Most men notice improvements in sy...
- What exactly is alfuzosin supposed to do for me?
- Yes, this one really does matter. Taking alfuzosin without food reduces the amount your body absorbs by about half, which means it won't work as well. Try to take it with the same...
- Does it matter if I take it with food? What if I forget to eat?
🕸️ Concept Web — How 24 HR alfuzosin hydrochloride 10 MG Extended Rel... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet
RxCUI 861132 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Alfuzosin
17300IN -
Alfuzosin hydrochloride
46043PIN
-
Alfuzosin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
UroXatral
356728BN
-
UroXatral
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Alfuzosin Extended Release Oral Tablet
370798SCDF -
Alfuzosin hydrochloride Extended Release Oral Tablet
2649232SCDFP -
Alfuzosin Oral Product
1164267SCDG -
Alfuzosin Pill
1164268SCDG -
Alfuzosin hydrochloride Oral Product
2660396SCDGP -
Alfuzosin hydrochloride Pill
2661004SCDGP -
Alfuzosin Extended Release Oral Tablet [UroXatral]
406325SBDF -
Alfuzosin hydrochloride Extended Release Oral Tablet [UroXatral]
2654872SBDFP - +5 more in this family
-
Alfuzosin Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Alfuzosin hydrochloride 10 MG
861131SCDC -
24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet [UroXatral]
861134SBD -
Alfuzosin hydrochloride 10 MG [UroXatral]
861133SBDC
-
Alfuzosin hydrochloride 10 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Alfuzosin hydrochloride 10 MG
SCDC · 861131 -
Alfuzosin Extended Release Oral Tablet
SCDF · 370798 -
Alfuzosin hydrochloride Extended Release Oral Tablet
SCDFP · 2649232 -
Alfuzosin Oral Product
SCDG · 1164267 -
Alfuzosin Pill
SCDG · 1164268 -
Alfuzosin hydrochloride Oral Product
SCDGP · 2660396 -
Alfuzosin hydrochloride Pill
SCDGP · 2661004
Brand-Name Concepts
-
24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet [UroXatral]
SBD · 861134 -
Alfuzosin hydrochloride 10 MG [UroXatral]
SBDC · 861133 -
Alfuzosin Extended Release Oral Tablet [UroXatral]
SBDF · 406325 -
Alfuzosin hydrochloride Extended Release Oral Tablet [UroXatral]
SBDFP · 2654872 -
UroXatral Oral Product
SBDG · 1186759 -
UroXatral Pill
SBDG · 1186760 -
UroXatral
BN · 356728
📦 FDA Products & Package NDCs
16 products · 49 package NDCs
49 package NDCs map to RxCUI 861132 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 29300-0155-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155... | Alfuzosin hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2016-03-15 |
| 29300-0155-13 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-... | Alfuzosin hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2016-03-15 |
| 29300-0155-19 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-... | Alfuzosin hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2016-03-15 |
| 43353-0945-16 | 6000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-945-16) | Alfuzosin hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | 2014-05-22 |
| 43353-0945-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-945-30) | Alfuzosin hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | 2015-04-02 |
| 43353-0945-60 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-945-60) | Alfuzosin hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | 2015-04-02 |
| 47335-0956-08 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-08) | Alfuzosin Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2011-11-22 |
| 47335-0956-18 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-18) | Alfuzosin Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2011-11-22 |
| 47335-0956-81 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-81) | Alfuzosin Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2011-11-22 |
| 47335-0956-83 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-83) | Alfuzosin Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2011-11-22 |
| 47335-0956-88 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-88) | Alfuzosin Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2011-11-22 |
| 51655-0087-52 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Alfuzosin Hydrochloride | Northwind Health Company, LLC | 2022-10-04 |
| 51655-0432-52 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-432-... | Alfuzosin Hydrochloride | Northwind Health Company, LLC | 2020-09-09 |
| 51655-0967-52 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-967-... | Alfuzosin hydrochloride | Northwind Health Company, LLC | 2023-06-29 |
| 57237-0114-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (57237... | Alfuzosin Hydrochloride | Rising Pharma Holdings, Inc. | 2012-08-30 |
| 57237-0114-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (57237... | Alfuzosin Hydrochloride | Rising Pharma Holdings, Inc. | 2012-08-30 |
| 57237-0114-90 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (57237-... | Alfuzosin Hydrochloride | Rising Pharma Holdings, Inc. | 2012-08-30 |
| 59212-0200-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10) | Uroxatral | Advanz Pharma (US) Corp. | 2013-06-03 |
| 59212-0200-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-30) | Uroxatral | Advanz Pharma (US) Corp. | 2019-01-18 |
| 60505-2850-09 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9) | Alfuzosin Hydrochloride | Apotex Corp. | 2023-09-08 |
| 63629-9155-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-9155... | Alfuzosin hydrochloride | Bryant Ranch Prepack | 2022-04-29 |
| 63629-9155-02 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-9155... | Alfuzosin hydrochloride | Bryant Ranch Prepack | 2022-04-29 |
| 63629-9155-03 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-9155... | Alfuzosin hydrochloride | Bryant Ranch Prepack | 2022-04-29 |
| 63629-9155-04 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-915... | Alfuzosin hydrochloride | Bryant Ranch Prepack | 2022-04-29 |
| 65862-0249-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862... | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | 2012-08-30 |
| 65862-0249-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862... | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | 2012-08-30 |
| 65862-0249-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-... | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | 2012-08-30 |
| 65862-0249-90 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-... | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | 2012-08-30 |
| 65862-0249-99 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (6586... | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | 2012-08-30 |
| 69097-0844-02 | 30 TABLET in 1 BOTTLE (69097-844-02) | Alfuzosin Hydrochloride extended release | Cipla USA Inc. | 2016-06-30 |
| 69097-0844-05 | 90 TABLET in 1 BOTTLE (69097-844-05) | Alfuzosin Hydrochloride extended release | Cipla USA Inc. | 2016-06-30 |
| 69097-0844-07 | 100 TABLET in 1 BOTTLE (69097-844-07) | Alfuzosin Hydrochloride extended release | Cipla USA Inc. | 2016-06-30 |
| 69097-0844-12 | 500 TABLET in 1 BOTTLE (69097-844-12) | Alfuzosin Hydrochloride extended release | Cipla USA Inc. | 2016-06-30 |
| 71335-2146-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-1) | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2024-04-03 |
| 71335-2146-02 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-2) | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2024-04-03 |
| 71335-2146-03 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-3) | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2023-01-30 |
| 71335-2146-04 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-4) | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2024-04-03 |
| 71335-2146-05 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2146-5) | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2024-04-03 |
| 71335-2578-01 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2025-02-06 |
| 71335-2578-02 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2025-02-06 |
| 71335-2578-03 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2025-02-06 |
| 71335-2578-04 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335... | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2025-02-06 |
| 71335-2578-05 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335... | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2025-02-06 |
| 72162-1449-09 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1449-9) | Alfuzosin Hydrochloride | Bryant Ranch Prepack | 2024-07-16 |
| 76282-0302-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-01) | Alfuzosin hydrochloride | Exelan Pharmaceuticals Inc. | 2012-10-02 |
| 76282-0302-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-05) | Alfuzosin hydrochloride | Exelan Pharmaceuticals Inc. | 2012-10-02 |
| 76282-0302-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-10) | Alfuzosin hydrochloride | Exelan Pharmaceuticals Inc. | 2012-10-02 |
| 76282-0302-12 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-12) | Alfuzosin hydrochloride | Exelan Pharmaceuticals Inc. | 2022-12-01 |
| 76282-0302-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-90) | Alfuzosin hydrochloride | Exelan Pharmaceuticals Inc. | 2019-01-01 |
Observed labelers:
Bryant Ranch Prepack (15) ·
Aurobindo Pharma Limited (5) ·
Exelan Pharmaceuticals Inc. (5) ·
Sun Pharmaceutical Industries, Inc. (5) ·
Cipla USA Inc. (4) ·
Aphena Pharma Solutions - Tennessee, LLC (3)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.